Market Overview

Mid-Afternoon Market Update: Cubic Tumbles Following Q4 Results; Hepion Pharmaceuticals Shares Climb


Toward the end of trading Thursday, the Dow traded down 0.01% to 27,818.51 while the NASDAQ fell 0.07% to 8,520.75. However, the S&P rose 0.01% to 3,108.51.

Leading and Lagging Sectors

Energy shares climbed 1.4% on Thursday. Meanwhile, top gainers in the sector included McDermott International, Inc. (NYSE: MDR), up 29%, and Pacific Drilling S.A. (NYSE: PACD), up 10%.

In trading on Thursday, real estate shares fell 1.1%.

Top Headline

Macy's Inc (NYSE: M) reported downbeat sales for its third quarter and lowered FY19 guidance.

Macy's reported third-quarter earnings of 7 cents per share on Thursday. This is a 74.07% decrease over earnings of 27 cents per share from the same period last year. The company reported quarterly sales of $5.173 billion, which missed the analyst consensus estimate of $5.32 billion.

Macy's cut fiscal year 2019 EPS guidance from $2.85-$3.05 to $2.57-$2.77 versus the $2.79 estimate. The company lowered FY19 same-store sales guidance from flat to up 1% to down 1-1.5%

Equities Trading UP

Hepion Pharmaceuticals, Inc. (NASDAQ: HEPA) shares shot up 43% to $3.45 after the thinly-traded, nano-cap biotech announced results from an animal study of its lead product candidate CRV431. New Jersey-based Hepion said CRV431 prevented the development of liver cirrhosis in a highly aggressive, preclinical model of liver disease.

Shares of Stage Stores, Inc. (NYSE: SSI) got a boost, shooting up 43% to $3.1784 after the company reported Q3 results.

TD Ameritrade Holding Corporation (NASDAQ: AMTD) shares were also up, gaining 18% to $49.01. Charles Schwab (NYSE: SCHW) is looking to acquire TD Ameritrade for $26 billion, Fox Business first reported. The deal could be announced as soon as today.

Equities Trading DOWN

InVivo Therapeutics Holdings Corp. (NASDAQ: NVIV) shares tumbled 31% to $0.16. InVivo Therapeutics priced its 7 million share offering at $0.12 per share for gross proceeds $840,000.

Shares of Cubic Corporation (NYSE: CUB) were down 19% to $59.59 after the company reported worse-than-expected Q4 EPS results. The company also issued FY20 EPS guidance below analyst estimates.

Karuna Therapeutics, Inc. (NASDAQ: KRTX) was down, falling 25% to $81.79 after the company reported an offering of 2.6 million shares of its common stock at $96 per share.


In commodity news, oil traded up 2.7% to $58.52, while gold traded down 0.7% to $1,463.90.

Silver traded down 0.4% Thursday to $17.045, while copper fell 0.9% to $2.6245.

Euro zone

European shares closed lower today. The eurozone’s STOXX 600 fell 0.4%, the Spanish Ibex Index fell 0.12%, while Italy’s FTSE MIB Index fell 0.31%. Meanwhile, the German DAX fell 0.16%, and the French CAC 40 fell 0.22% while UK shares fell 0.33%.


U.S. initial jobless claims were unchanged at 227,000 for the latest week. However, analysts were expecting a reading of 220,000.

The Philadelphia Fed manufacturing index increased to 10.4 for November, versus a reading of 5.6 in October.

U.S. existing home sales increased 1.9% to an annual rate of 5.46 million units in October, versus analysts’ expectations of 1.4% rise.

U.S. leading economic indicators declined 0.1% for October.

Domestic supplies of natural gas dropped 94 billion cubic feet for the week ended November 8, the U.S. Energy Information Administration reported. However, analysts projected a decline of 91 billion cubic feet.

Data on money supply for the recent week will be released at 4:30 p.m. ET.

Posted-In: Mid-Afternoon Market UpdateEarnings News Eurozone Commodities Global Intraday Update Markets


Related Articles (AMTD + CUB)

View Comments and Join the Discussion!
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at